Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract

Chakshu Research, Inc.80 enrolled

Overview

The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Cataract

Interventions

C-KAD Ophthalmic SolutionDRUG

4 drops applied daily for 120 days

PlaceboDRUG

4 drops applied daily for 120 days

Eligibility

Sex: ALLMin age: 50 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Presence of age-related cataract in the study eye * Best-corrected visual acuity of 20/25 to 20/50 in the study eye Exclusion Criteria: * Any other clinical condition in the eye that may compromise vision * Presence or History of Glaucoma * Presence or history of diabetes * Use of eyedrops * Use of steroids

Locations (4)

Pacific Eye Specialists

San Francisco, California, United States

RECRUITING

Hunkeler Eye Institute

Overland Park, Kansas, United States

RECRUITING

Minnesota Eye Consultants, PA

Minneapolis, Minnesota, United States

RECRUITING

Outcomes

Primary Outcomes

Best-corrected visual acuity by ETDRS

Time frame: 120 Days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.